Evidence map›Paper›PMID 26014307›Full record

ArticleThe American journal of managed care2015

Factors affecting medication adherence trajectories for patients with heart failure.

Deborah Taira Juarez, Andrew E Williams, Chuhe Chen, Yihe Goh Daida, Sara K Tanaka, Connie Mah Trinacty, Thomas M Vogt

Abstract read
In one paragraph

Article in The American journal of managed care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Medication Adherence Trajectories: A Systematic Literature Review.Journal of managed care & specialty pharmacy · 2020
    Pooled it
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Examining Factors Associated With Nonadherence And Identifying Providers Caring For Nonadherent Subgroups.Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Deborah Taira JuarezUniversity of Hawaii at Hilo, Daniel K. Inouye College of Pharmacy, 677 Ala Moana Blvd, Ste 1025, Honolulu, HI 96813. Email: dtjuarez@hawaii.edu.
Andrew E Williams
Chuhe Chen
Yihe Goh Daida
Sara K Tanaka
Connie Mah Trinacty
Thomas M Vogt

Funding

Disparities in Diabetes Care: Health Plan Focus and Physician ResponsivenessK01HS018072 · AHRQ · KAISER FOUNDATION RESEARCH INSTITUTE · PI TRINACTY, CONNIE MAH · 2009 to 2013
$767k
Using IT to Improve the Quality of CVD Prevention & ManagementR18HS017016 · AHRQ · KAISER FOUNDATION RESEARCH INSTITUTE · PI WILLIAMS, ANDREW EWING · 2007 to 2008
$602k
AHRQ HHS 5 R18 HS 017016AHRQ HHS K01 HS018072AHRQ HHS R18 HS017016
6 · The paper itself

Abstract

objectivesTo examine the relationship between patient characteristics and medication adherence trajectories for patients with congestive heart failure (CHF). STUDY

designHistorical prospective study.

methodsWe conducted a secondary analysis of data assembled for the Practice Variation and Care Outcomes (PRAVCO) study, which examined patterns of cardiovascular care. We used group based trajectory modeling to define medication adherence trajectories, and then modeled factors associated with belonging to a trajectory group during the 6year period from 2005 to 2010 (n = 10,986). We focused on the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) for secondary prevention of CHF.

resultsFour trajectory groups were optimal in characterizing adherence level patterns: 1) low adherence group, with an initial average adherence rate of 62% that dropped to between 40% and 50%; 2) increasing adherence group, with an initial average adherence rate of 55% that increased to 90%; 3) decreasing adherence group, with an initial average adherence rate above 90% that decreased to 60%; 4) high adherence group, with an average adherence rate consistently above 90%. Age, region, education, smoking, and race were all significantly associated with the likelihood of belonging to a particular trajectory. Nonwhites were less likely to be in the high adherence group, and smoking was more common in the low adherence group (22%) than in the high group (10%); increasing body mass index and Charlson Comorbidity Index (CCI) scores were also associated with being in the low adherence group.

conclusionsPopulation characteristics associated with sustained low adherence might be used to target interventions and improve vulnerable patients' prospects of heart health.

Indexed as

Medication AdherenceAgedAge FactorsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsEducational StatusFemaleHeart FailureHumansMaleMiddle AgedPacific StatesProspective StudiesRacial GroupsSmokingAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor Antagonists

Identifiers

PMID26014307
PMCPMC6358173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.